Table 3.
Multivariable regression results for overall survival and recurrence-free survival
| Characteristic | Overall survival |
Recurrence-free survival |
||
|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95% CI) | p-value | |
| Sex | 0.56 (0.24-1.32) | 0.184 | 0.36 (0.15-0.82) | 0.015 |
| Age | 0.95 (0.62-1.45) | 0.799 | 0.98 (0.68-1.42) | 0.915 |
| PLT | 0.77 (0.47-1.24) | 0.288 | 1.27 (0.82-1.97) | 0.289 |
| HBsAg | 1.02 (0.53-1.93) | 0.960 | 1.09 (0.63-1.89) | 0.764 |
| AFP | 1.37 (0.88-2.11) | 0.160 | 1.44 (0.99-2.08) | 0.052 |
| Capsulation | 1.51 (0.90-2.55) | 0.120 | 1.11 (0.70-1.77) | 0.643 |
| Bolondi’s subclassification | 1.31 (0.82-2.10) | 0.263 | 0.97 (0.65-1.46) | 0.892 |
| Lymphatic metastasis | 2.01 (0.81-4.98) | 0.131 | 1.49 (0.70-3.20) | 0.299 |
| Tumor size | 2.74 (1.58-4.74) | < 0.001 | 2.31 (1.42-3.74) | 0.001 |
HR, hazard ratio; CI, confidence interval; PLT, platelet; HBsAg, hepatitis B surface antigen; AFP, α-fetoprotein.